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A B S T R A C T
Disseminated gonococcal infection (DGI) occurs in 1–3% of all gonococcal infections; endocarditis is a
complication in 1–2% of patients with DGI. We present the fourth reported case of gonococcal tricuspid
valve endocarditis, this one occurring in a 53-year-old male with a 2-month history of shortness of
breath.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Disseminated gonococcal infection (DGI) occurs in 1–3% of all
gonococcal infections, and endocarditis is a complication in 1–2%
of patients with DGI.1–4 The number of reported cases has
decreased with the advent of antibiotics.1,5,6 There are only two
case reports of tricuspid valve involvement occurring in the post-
antibiotic era.2,3 In both reports, the patients were young and had a
past history of gonococcal infection.2,3 We present herein a case of
gonococcal tricuspid valve endocarditis in a 53-year-oldmale with
no history of known gonococcal infection, heart disease, or valve
replacement.
2. Case report
A 53-year-old male presented with a 2-month history of
progressive shortness of breath, which was initially noted on
exertion and then present at rest. He also complained of
generalized weakness, subjective fevers, chills, and weight loss
for several weeks. A review of systems was signiﬁcant for night
sweats, lower extremity edema, chronic cough, and abdominal
discomfort for 2–3 months. He denied paroxysmal nocturnal
dyspnea and orthopnea. His past medical history was signiﬁcant* Corresponding author.
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denied any sexually transmitted diseases or high risk sexual
behavior. However, during a primary care visit 6 months later, the
patient acknowledged unprotected heterosexual encounters with
multiple partners.
Physical examination revealed an acutely ill appearing male
with an oral temperature of 37.8 8C, a blood pressure of 135/73
mmHg, a heart rate of 115 permin, a respiratory rate of 20 permin,
and an oxygen saturation of 98% on room air. A skin examination
did not reveal any rashes or abnormalities. Cardiac examination
revealed a non-radiating, soft 2/6 systolic murmur in the left
parasternal region, an undisplaced point of maximal impulse, and
no jugular venous distention. He had hepatomegaly and bilateral
pitting edema up to the knees. The patient did not have ﬁndings of
tenosynovitis or septic arthritis. Laboratory data were signiﬁcant
for microcytic anemia with a hemoglobin level of 7.6 g/dl and a
leukocyte count of 20.4  109 cells/l, with 74% neutrophils, 6%
bands, and 12% lymphocytes in the differential. A toxicology screen
was negative and a 12-lead electrocardiogram was normal.
The admitting diagnosis was congestive heart failure (CHF)
secondary to anemia. The patient received 2 units of packed red
blood cells and empiric antibiotics (vancomycin and piperacillin/
tazobactam). The latter were started because the patient was
febrile and acutely ill, even though there was no obvious source of
infection. A transthoracic echocardiogram showed a large tricuspid
valve vegetation with moderate regurgitation. On the third day of
admission, three different sets of blood cultures drawn in a span ofses. Published by Elsevier Ltd. All rights reserved.
Table 1
Summary of reported tricuspid valve gonococcal endocarditis in the post-antibiotic era
Author [Ref.] Age (years)/sex Previous gonococcal
infection
Clinical presentation Antibiotics Complications Outcome
Fernandez et al. [6] 35/M Treated for
urethritis
Cough, malaise,
arthralgia, CHF
Vancomycin, penicillin
(6 weeks)
None Alive
Jackman and Glamann [2] 22/M Treated for
urethritis
Chest pain, chills Penicillin (4 weeks) None Alive
John et al. [4] 18/M No Fever, abdominal pain Penicillin (6 weeks) None Alive
Current case 53/M No Fever, chills, weight loss,
shortness of breath
Ceftriaxone (6 weeks) None Alive
M, male; CHF, congestive heart failure.
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with DNA probe conﬁrmation. The bacteria in all the cultures were
sensitive to ceftriaxone (minimum inhibitory concentration (MIC)
dilution 0.04mg/ml) and resistant to ampicillin/penicillin by b-
lactamase screening. No ciproﬂoxacin sensitivities were con-
ducted. The urethral and throat swabs cultured in Thayer–Martin
medium were negative for gonorrhea; however, these samples
were collected after the patient had already received empiric
antibiotics. No urine PCR was obtained.
The patient improved on intravenous ceftriaxone. Surveillance
blood cultures drawn 12, 46, and 84 days after admission (the
latter set drawn 6 weeks after completion of antibiotics) were
negative. A second echocardiogram done 6weeks later revealed no
increase in the size of the tricuspid vegetation or worsening of
regurgitation. The patient has been asymptomatic for the last 6
months.
3. Discussion
Gonorrhea remains a major bacterial pathogen with high
disease incidence in developing countries and an increasing rate of
incidence in developed countries.7 One of the reasons for a steady
increase in the incidence of gonorrhea worldwide is because of the
ability of gonococcus to develop antibiotic resistance.7 In the USA,
gonorrhea remains the second most commonly reported commu-
nicable disease with over 300 000 cases reported annually, and
there are many cases that are not reported.1,8 The highest reported
rates of gonococcal infection are seen among adolescents, young
adults, and among the population of southeastern USA.8 After
dissemination of penicillinase-producing and ﬂuoroquinolone-
resistant Neisseria gonorrhoeae, the recommendations in the USA
have recently been modiﬁed to exclude quinolones as a standard
treatment for gonorrhea.7 This resistance pattern is alarming
and suggests that the incidence of the infection may continue to
rise in the future if strong preventive measures are not
implemented.
In the pre-antibiotic era, N. gonorrhoeae was the third leading
cause of infective endocarditis, accounting for 11–26% of all cases.
It was reported to have very high mortality rates.2,3 Even with the
advent of antibiotics the mortality rates are high, around 20%.2
Patients with gonococcal endocarditis (GE) usually present with
non-speciﬁc symptoms, such as myalgias, arthralgias, fever, chills,
a maculopapular rash, and back pain. However, most patients have
prominent cardiac abnormalities, such as CHF and/or a newmurmur. The aortic valve is involved in 50% of cases, followed by
the mitral valve in 30% of cases.6 Historically diagnosing GE has
been challenging, because Neisseria is difﬁcult to grow even with
appropriate culture media. On average, more than six blood
cultures are required.10 With the advent of nucleic acid ampliﬁca-
tion techniques, the detection of bacteremia has become easier. GE
is an aggressive infection thatmay cause valve destruction in hours
to days, even if the patient has been treated with appropriate
antibiotics.1,2,9 Fifty percent of patients require valve replace-
ment.1
GE differs from other causes of bacterial endocarditis in some
respects. The duration from the onset of symptoms to diagnosis is
usually longer for GE than for other pathogens like Staphylococcus
aureus and pneumococcal endocarditis, but shorter and more
aggressive than viridans Streptococcus, enterococcal, and other
Gram-negative endocarditis.5
Our case illustrates the fact that patients with GE present with
non-speciﬁc symptoms (see Table 1). Our patient came with fever,
weakness, night sweats, and weight loss. Although GE is rare, it
should be suspected in patients with risk factors for sexually
transmitted diseases and arthritis. Lack of prior urethritis does not
rule out the diagnosis. Unlike the common presentation of aortic
GE, which requires valve replacement, tricuspid GE is cured by
medical therapy.
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